Bridgeway Capital Management’s Protalix BioTherapeutics PLX Stock Holding History

Bridgeway Capital Management’s Portfolio PLX Stock Details PLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$410K	Hold	189,100	–	–	0.01%	853
2025 Q4	$340K	Hold	189,100	–	–	0.01%	900
2025 Q3	$420K	Hold	189,100	–	–	0.01%	837
2025 Q2	$280K	Hold	189,100	–	–	0.01%	881
2025 Q1	$484K	Buy	189,100 +7,700	+4%	+$18.4K	0.01%	750
2024 Q4	$341K	Sell	181,400 -2,390	-1%	-$3.38K	0.01%	896
2024 Q3	$187K	Hold	183,790	–	–	﹤0.01%	1080
2024 Q2	$215K	Hold	183,790	–	–	0.01%	1049
2024 Q1	$232K	Sell	183,790 -25,000	-12%	-$37.3K	﹤0.01%	1078
2023 Q4	$372K	Buy	208,790 +50,000	+31%	+$77.8K	0.01%	1013
2023 Q3	$264K	Hold	158,790	–	–	0.01%	1036
2023 Q2	$318K	Buy	158,790 +25,000	+19%	+$59.6K	0.01%	1032
2023 Q1	$281K	Hold	133,790	–	–	0.01%	1030
2022 Q4	$183K	Hold	133,790	–	–	﹤0.01%	1103
2022 Q3	$139K	Sell	133,790 -25,000	-16%	-$27.7K	﹤0.01%	1215
2022 Q2	$173K	Buy	158,790 +130,000	+452%	+$152K	﹤0.01%	1121
2022 Q1	$31K	Buy	+28,790	New	+$26.4K	﹤0.01%	1301
2021 Q4	–	Sell	-58,890	Closed	-$78K	–	1318
2021 Q3	$78K	Sell	58,890 -335,000	-85%	-$509K	﹤0.01%	1262
2021 Q2	$752K	Buy	393,890 +91,299	+30%	+$314K	0.01%	949
2021 Q1	$1.35M	Buy	302,591 +90,000	+42%	+$419K	0.03%	759
2020 Q4	$772K	Hold	212,591	–	–	0.02%	808
2020 Q3	$823K	Buy	212,591 +38,300	+22%	+$138K	0.02%	733
2020 Q2	$661K	Buy	174,291 +84,799	+95%	+$290K	0.01%	777
2020 Q1	$210K	Buy	+89,492	New	+$296K	﹤0.01%	1047
2019 Q4	–	Sell	-20,259	Closed	-$42K	–	1374
2019 Q3	$42K	Hold	20,259	–	–	﹤0.01%	1283
2019 Q2	$95K	Hold	20,259	–	–	﹤0.01%	1247
2019 Q1	$89K	Hold	20,259	–	–	﹤0.01%	1286
2018 Q4	$63K	Hold	20,259	–	–	﹤0.01%	1330
2018 Q3	$147K	Hold	20,259	–	–	﹤0.01%	1353
2018 Q2	$87K	Sell	20,259 -10,000	-33%	-$44.5K	﹤0.01%	1372
2018 Q1	$163K	Hold	30,259	–	–	﹤0.01%	1288
2017 Q4	$200K	Hold	30,259	–	–	﹤0.01%	1276
2017 Q3	$176K	Hold	30,259	–	–	﹤0.01%	1297
2017 Q2	$253K	Hold	30,259	–	–	﹤0.01%	1240
2017 Q1	$412K	Hold	30,259	–	–	0.01%	1123
2016 Q4	$135K	Hold	30,259	–	–	﹤0.01%	1347
2016 Q3	$169K	Hold	30,259	–	–	﹤0.01%	1344
2016 Q2	$194K	Sell	30,259 -4,696	-13%	-$37.5K	﹤0.01%	1308
2016 Q1	$294K	Hold	34,955	–	–	﹤0.01%	1218
2015 Q4	$357K	Hold	34,955	–	–	0.01%	1161
2015 Q3	$412K	Buy	34,955 +2,221	+7%	+$35.3K	0.01%	1119
2015 Q2	$638K	Buy	32,734 +2,651	+9%	+$55K	0.01%	955
2015 Q1	$535K	Buy	30,083 +5,202	+21%	+$102K	0.01%	1074
2014 Q4	$458K	Buy	24,881 +4,881	+24%	+$105K	0.01%	1105
2014 Q3	$484K	Buy	+20,000	New	+$576K	0.01%	1085